Role of CD8 T cell-mediated Pathology in Globoid Cell Leukodystrophy
CD8 T 细胞介导的病理学在球状细胞脑白质营养不良中的作用
基本信息
- 批准号:10634808
- 负责人:
- 金额:$ 51.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:5 year oldAddressAffectAntibodiesAntigen-Presenting CellsAntigensAutomobile DrivingBehavioralBiochemicalBloodBody Weight decreasedBrainCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell TherapyCellsCellular ImmunityCentral Nervous SystemCentral Nervous System DiseasesCessation of lifeChildClinicalCognitive deficitsComplexCytometryCytotoxic T-LymphocytesDataDemyelinationsDevelopmentDiseaseEffectivenessFlow CytometryFutureGenesGeneticGenetic DiseasesGloboid cell leukodystrophyHistologicHumanImageImmuneImmunityInflammationInflammatoryInvestigational TherapiesKnockout MiceKnowledgeLesionLife ExpectancyLipidsLive BirthLocationLongevityMapsMediatingMeningealModelingMolecularMotorMusMutationNatureNerve DegenerationNerve TissueNonsense CodonOligodendrogliaOnset of illnessOutcomeOutcome MeasureOutcome StudyParalysedPathogenesisPathogenicityPathologicPathologyPhenotypePlayPopulationProcessPsychosineReporter GenesRoleT cell clonalityT-Cell DepletionT-LymphocyteTechnologyTestingTherapeuticTherapeutic InterventionTimeTissuesTransgenic AnimalsTransgenic Organismsadaptive immunitybrain tissuecell typecentral nervous system demyelinating disordercytokinecytotoxic CD8 T cellscytotoxicitydefined contributiondisabilitygalactosylceramidasegene therapygenetic approachgenetic profilingimprovedinsightloss of functionloss of function mutationmouse modelmultidisciplinaryneuroinflammationneuropathologynovelpharmacologicpostnatalpreservationpreventresponsesingle-cell RNA sequencingspatial relationshipsuccesstooltranscriptome sequencingtranscriptomicswhite matter
项目摘要
Abstract
Globoid cell leukodystrophy (GLD) or Krabbe's disease is a fatal genetic demyelinating disease of the central
nervous system affecting 1 in 100,000 live births with no cure or effective long-term treatment. GLD is caused
by loss-of-function mutations in the galactosylceramidase (galc) gene, where loss of GALC enzymatic function
results in toxic accumulation of its substrate, a lipid called galactosylsphingosine or `psychosine'. Psychosine
cytotoxicity is considered the basis of several key pathologies in GLD. Neuropathology in GLD is marked by
profound demyelination and inflammation. However, molecular details of these processes are limited, leaving
few therapeutic options. Early histological evidence for CD8+ T cells within demyelinated lesions in both the twi
mouse brain and human GLD brain had suggested a role for adaptive immunity in this disease. However, the
function of CD8+ T cells in GLD has not been previously determined. To address this gap in our knowledge, we
analyzed the timing of T cell population changes by flow cytometry in CNS tissues from the twitcher mouse
model of GLD and compared with wt littermates. We identified a rapid and protracted elevation of T cells in the
twi CNS that was coincident with the onset of clinical disease at postnatal day 21 (P21). These data were
confirmed using single-cell RNA sequencing on twi and wt littermate brain tissues from which identified a 9-fold
increase in CD8+ T cells in twi mouse brains at P21. Our transcriptomic data also defined the CD8+ population
as cytotoxic T lymphocytes (CTLs). To test the function of CD8+ CTLs in GLD-like disease in twi mice, we
depleted CD8+ T cells by administering anti-CD8 antibody to twi mice and found that this treatment effectively
prevented disease onset, preserved wellness and completely prevented CNS demyelination while also
attenuating pro-inflammatory cytokine levels in brain and blood. These novel and highly translational data
portend a pathogenic role for CD8+ T cells in GLD and underlie the basis for our overall hypothesis that CD8+
T cells are pathogenic in GLD and directly contribute to disease. Accordingly, Aim 1 will characterize the
spatial and temporal development of CD8+ T cells in twi mice and challenge the contribution of CD8+ T cells
using knockout mouse lines to then assess clinical, biochemical, and pathological outcomes. Aim 2 will define
the overall nature of adaptive immunity by evaluating contribution of CD4+ T cells to CD8+ T cell-mediated
immunity in twi mice using targeted depletion and genetic strategies. Aim 3 will identify and profile the timing,
and location T cells responding to authentic antigen, the clonality of the T cells using T cell β chain VDJ
phenotyping, and then identify the nature of the antigen presenting cell types using transgenic reporter mice.
These multi-disciplinary studies will interrogate a previously unrecognized CD8+ T cell neuroinflammatory
response in GLD. Outcomes of these studies are expected to fill an important gap in our understanding on the
fundamental cellular pathological mechanisms underlying the development CD8+ T cell mediated
neuropathology and disease in GLD.
摘要
球样细胞脑白质营养不良(GLD)或克拉伯病是一种致命的遗传性中枢神经系统脱髓鞘疾病,
神经系统感染,每100,000名活产婴儿中就有1人感染,无法治愈或有效的长期治疗。GLD是由
由于半乳糖神经酰胺酶(galc)基因功能丧失突变,GALC酶功能丧失
导致其底物(一种称为半乳糖基鞘氨醇或“psychosine”的脂质)的毒性积累。三嗪
细胞毒性被认为是GLD中几种关键病理的基础。GLD的神经病理学特征为:
严重的脱髓鞘和炎症然而,这些过程的分子细节是有限的,
很少有治疗选择。两组脱髓鞘病变中CD8+ T细胞的早期组织学证据,
小鼠脑和人类GLD脑表明了适应性免疫在这种疾病中的作用。但
先前尚未确定⑶ 8 + T细胞在GLD中的功能。为了弥补我们知识上的差距,我们
通过流式细胞术分析了ticker小鼠CNS组织中T细胞群变化的时间
模型,并与野生型同窝仔进行比较。我们发现,T细胞的快速和持久的升高,
与出生后第21天(P21)临床疾病发作一致的twi CNS。这些数据
在twi和wt同窝出生的脑组织上使用单细胞RNA测序证实,从中鉴定出9倍的
在P21时Twi小鼠脑中的CD8+ T细胞增加。我们的转录组学数据还定义了CD8+群体
如细胞毒性T淋巴细胞(CTL)。为了测试CD8+ CTL在twi小鼠中的GLD样疾病中的功能,我们
通过向twi小鼠施用抗CD8抗体来耗尽CD8+ T细胞,并发现这种治疗有效地
预防疾病发作,保持健康并完全预防CNS脱髓鞘,同时还
减弱脑和血液中的促炎细胞因子水平。这些新的高度翻译的数据
这预示着CD8+ T细胞在GLD中的致病作用,并为我们的总体假设奠定了基础,即CD8+ T细胞在GLD中的致病作用可能是CD8+ T细胞在GLD中的致病作用。
T细胞在GLD中是致病性的,并直接导致疾病。因此,目标1将描述
双鼠中CD 8 + T细胞的空间和时间发育并挑战CD 8 + T细胞的贡献
使用基因敲除小鼠品系,然后评估临床、生化和病理结果。目标2将定义
通过评估CD4+ T细胞对CD8+ T细胞介导的免疫应答的贡献,
使用靶向消耗和遗传策略在twi小鼠中的免疫力。目标3将确定和描绘时间,
和定位对真实抗原应答的T细胞,使用T细胞β链VDJ检测T细胞的克隆性
表型分型,然后使用转基因报告小鼠鉴定抗原呈递细胞类型的性质。
这些多学科研究将探讨以前未被认识到的CD8+ T细胞神经炎性
在GLD的回答。这些研究的结果有望填补我们对这一问题的认识上的一个重要空白。
CD8+ T细胞介导的发育的基本细胞病理学机制
神经病理学和GLD疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephen J Crocker其他文献
Stephen J Crocker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephen J Crocker', 18)}}的其他基金
The Contribution of Central Nervous System Demyelination to Bladder Dysfuntion
中枢神经系统脱髓鞘对膀胱功能障碍的影响
- 批准号:
10352892 - 财政年份:2021
- 资助金额:
$ 51.91万 - 项目类别:
Proteomic and Functional Analyses of Astrocyte Exosomes
星形胶质细胞外泌体的蛋白质组学和功能分析
- 批准号:
8893411 - 财政年份:2015
- 资助金额:
$ 51.91万 - 项目类别:
Development of a conditional T1MP-1 knockout mouse
条件性T1MP-1基因敲除小鼠的研制
- 批准号:
8417649 - 财政年份:2012
- 资助金额:
$ 51.91万 - 项目类别:
Development of a conditional T1MP-1 knockout mouse
条件性T1MP-1基因敲除小鼠的研制
- 批准号:
8283645 - 财政年份:2012
- 资助金额:
$ 51.91万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 51.91万 - 项目类别:
Research Grant